The United States spends many billions of dollars on medical devices annually; cardiac devices are a significant component of these expenditures. Device pricing is quite hidden because patients are rarely billed separately for devices; rather, devices are part of a package. Many hospitals have committees that determine which type and brand of devices to use and may negotiate pricing as well. Again, these prices and negotiations are secret. Commonly, physicians are key participants in those decisions.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Redberg RF. Interventional Cardiology Payments and Device Choices—The Ties That (May) Blind. JAMA Intern Med. Published online June 17, 2019. doi:10.1001/jamainternmed.2018.8737
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: